Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Medicina Clinica (English Ed.)|August 30, 2021
Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxisPedro M García-Ceberino, Naya Faro-Míguez, Francisco Javier Beltrán-Ávila, et al.
Medicina Clinica (English Ed.)|April 15, 2020
Chikungunya fever - A new global threatAntonio Montero
Medicina Clinica (English Ed.)|April 15, 2020
Zika virus infection or the future of infectious diseasesLluís Valerio Sallent, Sílvia Roure Díez, Gema Fernández Rivas
Medicina Clinica (English Ed.)|May 19, 2021
Point-of-care ultrasonography in the initial characterization of patients with COVID-19Yale Tung-Chen, Ana Algora-Martín, Rafael Llamas-Fuentes, et al.
Medicina Clinica (English Ed.)|October 24, 2022
Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registryJavier Azaña Gómez, Luis M Pérez-Belmonte, Manuel Rubio-Rivas, et al.
Medicina Clinica (English Ed.)|September 12, 2022
Postintensive care syndrome in COVID-19. Unicentric pilot study. Calm does not come after the stormEva Mateo Rodríguez, Francesc Puchades Gimeno, Aida Ezzeddine Angulo, et al.
Medicina Clinica (English Ed.)|July 6, 2021
Application of validated severity scores for pneumonia caused by SARS-CoV-2Violeta Esteban Ronda, Sandra Ruiz Alcaraz, Paloma Ruiz Torregrosa, et al.
Medicina Clinica (English Ed.)|May 31, 2022
Influence of influenza vaccine and comorbidity on the evolution of hospitalized COVID-19 patients⋆José Manuel Fernández Ibáñez, María Del Carmen Morales Ballesteros, Manuel José Fernández Anguita, et al.
Medicina Clinica (English Ed.)|May 9, 2022
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysisÁlvaro Aparisi, Pablo Catalá, Ignacio J Amat-Santos, et al.
Medicina Clinica (English Ed.)|May 9, 2022
Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumoniaIgnacio Cardona-Pascual, David Berlana, Ferran Martinez-Valle, et al.
Pageof 11